These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30844559)

  • 1. The role of interleukin-13 in chronic inflammatory intestinal disorders.
    Giuffrida P; Caprioli F; Facciotti F; Di Sabatino A
    Autoimmun Rev; 2019 May; 18(5):549-555. PubMed ID: 30844559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer T cells and ulcerative colitis.
    Lai LJ; Shen J; Ran ZH
    Cell Immunol; 2019 Jan; 335():1-5. PubMed ID: 30638678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of a role for interleukin-13 in inflammatory bowel disease.
    Biancheri P; Di Sabatino A; Ammoscato F; Facciotti F; Caprioli F; Curciarello R; Hoque SS; Ghanbari A; Joe-Njoku I; Giuffrida P; Rovedatti L; Geginat J; Corazza GR; MacDonald TT
    Eur J Immunol; 2014 Feb; 44(2):370-85. PubMed ID: 24338958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT6 deficiency ameliorates severity of oxazolone colitis by decreasing expression of claudin-2 and Th2-inducing cytokines.
    Rosen MJ; Chaturvedi R; Washington MK; Kuhnhein LA; Moore PD; Coggeshall SS; McDonough EM; Weitkamp JH; Singh AB; Coburn LA; Williams CS; Yan F; Van Kaer L; Peebles RS; Wilson KT
    J Immunol; 2013 Feb; 190(4):1849-58. PubMed ID: 23303670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR).
    Niessner M; Volk BA
    Clin Exp Immunol; 1995 Sep; 101(3):428-35. PubMed ID: 7664489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of IL-13 and NK T cells in experimental and human ulcerative colitis.
    Fuss IJ; Strober W
    Mucosal Immunol; 2008 Nov; 1 Suppl 1(0 1):S31-3. PubMed ID: 19079225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased mucosal interleukin-4 (IL-4) production in gut inflammation.
    Karttunnen R; Breese EJ; Walker-Smith JA; MacDonald TT
    J Clin Pathol; 1994 Nov; 47(11):1015-8. PubMed ID: 7829675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of type 2 immunity in intestinal inflammation.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2015 Nov; 31(6):471-6. PubMed ID: 26376478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for interleukin-33 in T(H)2-polarized intestinal inflammation?
    Seidelin JB; Rogler G; Nielsen OH
    Mucosal Immunol; 2011 Sep; 4(5):496-502. PubMed ID: 21613987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New mediators of immunity and inflammation in inflammatory bowel disease.
    Monteleone G; Fina D; Caruso R; Pallone F
    Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor alpha chain-deficient mice.
    Iijima H; Takahashi I; Kishi D; Kim JK; Kawano S; Hori M; Kiyono H
    J Exp Med; 1999 Sep; 190(5):607-15. PubMed ID: 10477546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease.
    Mencarelli A; Renga B; Palladino G; Distrutti E; Fiorucci S
    Biochem Pharmacol; 2009 Nov; 78(9):1214-23. PubMed ID: 19555671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune mechanisms in chronic inflammatory bowel disease.
    Braegger CP; MacDonald TT
    Ann Allergy; 1994 Feb; 72(2):135-41. PubMed ID: 8109803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of interleukin 17 in inflammatory bowel disease.
    Fujino S; Andoh A; Bamba S; Ogawa A; Hata K; Araki Y; Bamba T; Fujiyama Y
    Gut; 2003 Jan; 52(1):65-70. PubMed ID: 12477762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cells that produce immunoglobulin E mediate colitis in BALB/c mice.
    Hoving JC; Kirstein F; Nieuwenhuizen NE; Fick LC; Hobeika E; Reth M; Brombacher F
    Gastroenterology; 2012 Jan; 142(1):96-108. PubMed ID: 21983080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.